Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

47.500
-1.340-2.74%
Volume:24.25M
Turnover:1.16B
Market Cap:197.36B
PE:35.03
High:49.000
Open:48.460
Low:47.140
Close:48.840
52wk High:54.450
52wk Low:28.480
Shares:4.15B
HK Float Shares:4.15B
Volume Ratio:0.78
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.356
ROE:11.38%
ROA:7.60%
PB:3.51
PE(LYR):35.03
PS:7.15

Loading ...

Whitehawk Q2 FY26 Net Loss Narrows to $16.64 Million

Reuters
·
Aug 06

Wuxi Biologics (Cayman) Stock Advances 1.9% in Hong Kong

Dow Jones
·
Aug 06

Movement Alert|WUXI BIO Rises 3.1% in Regular Trading, CXO Sector Strength and Interim Earnings Expectations Serve as Catalysts

Market Focus
·
Aug 06

Wuxi Biologics (Cayman) Stock Climbs 4.3% in Hong Kong

Dow Jones
·
Aug 04

CRO Stocks Surge: Multiple Overseas MNCs and CXO Firms Report Strong Interim Results, Raise Full-Year Guidance

Stock News
·
Aug 04

Hong Kong Market Opens Higher as Pharma and Tech Stocks Lead Gains

Stock News
·
Aug 04

Movement Alert|WUXI BIO Rises 4.85% in Regular Trading, CXO Sector Broad Rally Lifts Life Sciences Stocks

Market Focus
·
Aug 04

Wuxi Biologics (Cayman) Stock Rallies 2.5% in Hong Kong

Dow Jones
·
Jul 31

Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%

Stock News
·
Jul 31

Movement Alert|WUXI BIO Rises 3.07% in Regular Trading, CXO Sector Rallies on Accelerating Industry Recovery

Market Focus
·
Jul 31

Wuxi Biologics (Cayman) Stock Slips 4.0% in Hong Kong

Dow Jones
·
Jul 30

Movement Alert|WUXI BIO Falls 3.15% in Regular Trading, Life Sciences Sector Broadly Weakens as Subsidiary Faces Target Price Cut

Market Focus
·
Jul 30

WuXi Biologics Added to FTSE4Good Index Series for Sixth Straight Year

Reuters
·
Jul 29

Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$51.38 From HK$50.54, Keeps at Buy

MT Newswires Live
·
Jul 27

WuXi Biologics Schedules 25 August Board Meeting to Approve H1 2026 Results

Bulletin Express
·
Jul 24

Wuxi Biologics Schedules Board Meeting to Review Interim Results

Reuters
·
Jul 24

Wuxi Biologics (cayman) Stock Rises 1.5% in Hong Kong

Dow Jones
·
Jul 21

Wuxi Biologics (cayman) Stock Advances 3.5% in Hong Kong

Dow Jones
·
Jul 20

HK Movers | Biomedical Stocks Rally; REMEGEN, WUXI XDC and KEYMED BIO-B Surge Over 8%

Tiger Newspress
·
Jul 20

Movement Alert|WuXi Biologics Rises 3.24% in Regular Trading, Star Fund Manager Zhao Feng Adds Stock as New Top-10 Holding

Market Focus
·
Jul 20